DFTX Definium Therapeutics, Inc.
Company Analysis
Latest News
🔴 Definium Therapeutics, Inc. is trading 5.1% down today as hot jobs data fuels interest rate concerns
Definium Therapeutics, Inc. is trading 5.1% down at $23.34 after a hotter-than-expected U.S. jobs report pushed interest rate expectations higher and pressured...
🔴 Definium Therapeutics, Inc. is trading 4.1% down today as strong U.S. jobs data fuels rate concerns
Definium Therapeutics, Inc. is trading 4.1% down at $23.58 today as a stronger-than-expected U.S. jobs report and rising interest rate expectations weigh on...
🟢 Definium Therapeutics, Inc. up 5% as investors anticipate key Phase 3 data
Definium Therapeutics, Inc. is trading at $24.78 (+5.04%) as investor anticipation builds ahead of key clinical trial results and following a positive...
🔴 Definium Therapeutics, Inc. is trading 6% down today as selling pressure persists following its Q1 2026 earnings miss
Definium Therapeutics, Inc. is trading 6% down at $22.61 as selling pressure persists following its recent Q1 2026 earnings miss and soft investor reaction. •...
🔴 Definium Therapeutics, Inc. is trading 6% down today as post-earnings weakness persists
Definium Therapeutics, Inc. is trading 6% down at $22.61 as the stock continues to face pressure following its Q1 2026 earnings disappointment. • The...
🔴 Definium Therapeutics, Inc. is trading 6.11% down
DFTX is trading at $22.59, down 6.11%.
🔴 Definium Therapeutics, Inc. is trading 4.8% down today as post-earnings weakness continues
Definium Therapeutics, Inc. is trading 4.8% down at $22.91, extending its decline following a disappointing Q1 2026 earnings report. • The company recently...